Release Date: 02/05/17 10:01 Summary: Repayment of Vendor Note and Update Price Sensitive: Yes Download Document 328.71KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%